Recombinant Hamster Ovary Cell Hepatitis B Vaccine Market

Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chinese hamster ovary cell (CHO) hepatitis B vaccine is considered to be the safe and effective method to prevent the hepatitis B infection. The major factor that fuels the growth of the market are increase in prevalence of hepatitis B infection worldwide. For example, approximately 887,000 deaths due to hepatitis B infection were recorded in 2015 across the globe. However, inherent disadvantages of using recombinant Chinese hamster ovary cell (CHO) to design hepatitis B vaccines restrains the growth of the market. Conversely, increase in government focus to promote (CHO) hepatitis B vaccination for adults and extensive research carried out for the same are expected to offer lucrative opportunities for the market.

Recombinant Hamster Ovary Cell Hepatitis B Vaccine Market aims to provide a comprehensive presentation of the global market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine. Recombinant Hamster Ovary Cell Hepatitis B Vaccine Market contains market size and forecasts of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in global, including the following market information:

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Sales, 2018-2023, 2024-2029, (K Doses)

Global top five Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine companies in 2022 (%)

The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.

Pediatric Hepatitis B (CHO) Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine include Merck & Co., Inc., GlaxoSmithKline Plc, Pfizer Inc., Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Serum Institute of India and Johnson & Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment Percentages, by Type, 2022 (%)

Pediatric Hepatitis B (CHO) Vaccine

Adult Hepatitis B (CHO) Vaccine

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Doses)

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment Percentages, by Application, 2022 (%)

Hospitals

Clinics

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)

Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine revenues share in global market, 2022 (%)

Key companies Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine sales in global market, 2018-2023 (Estimated), (K Doses)

Key companies Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Merck & Co., Inc.

GlaxoSmithKline Plc

Pfizer Inc.

Sanofi Pasteur

CSL Limited

Emergent Biosolutions

Serum Institute of India

Johnson & Johnson

Outline of Major Chapters:

Chapter 1: Introduces the definition of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, market overview.

Chapter 2: Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market size in revenue and volume.

Chapter 3: Detailed analysis of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.